Genor Biopharma Holdings Limited (HK:6998) has released an update.
Genor Biopharma Holdings Limited has announced the composition of its Board of Directors, which includes Executive Director Mr. Weng Chengyi, Non-executive Directors Dr. Lyu Dong and others, as well as Independent non-executive Directors Mr. Fung Edwin and colleagues. Additionally, the company has detailed the membership of its three key committees: Audit, Compensation, and Nomination, with Mr. Fung Edwin serving as Chairman of the Audit and Nomination committees.
For further insights into HK:6998 stock, check out TipRanks’ Stock Analysis page.